Patient Access and Delivery of Advanced Therapies – Part 2

Phacilitate
23 June 2019

An interview with Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine, Massachusetts General Hospital.

Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine at Massachusetts General Hospital, gives the clinician’s perspective on patient access and delivery of advanced therapies and answers four crucial questions:

1.Are specific centres of excellence the answer to improving patient access to advanced therapies and clinical trials?

2.Is the next generation of cellular immunotherapies agnostic?

3.Can you share some of the cellular immunotherapy initiatives going on at Mass General Cancer Center?

4.What role, if any, can clinicians play in working with payers to secure funding for ATMPs?

Phacilitate member? Register for the live event and on-demand access via the network.